Category

Health Economics Review

Home > Papers-Magazines > Health Economics Review

Flor-Lorente B, Noguer-Aguilar JF, Delgado-Rivilla S, García-González JM, Rodriguez-Martín M, Salinas-Ortega L, Casado MA, Álvarez M

 

 

The economic impact of anastomotic leak after colorectal cancer surgery
Health Econ Rev 13, 12 (2023)

Gros B, Galan A, Gonzalez-Parra E, Herrero JA, Echave M, Vegter S, Tolley K, Oyagüez I

 

 

Cost effectiveness of Lanthanum Carbonate in chronic kidney disease patients in Spain before and during dialysis
Health Econ Rev. 2015;5:14 doi:10.1186/s13561-015-0049-3

Sanchez-de la Rosa R, Sabater E, Casado MA

 

 

 

Cost analysis of glatiramer acetate vs. Fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
Health Econ Rev. 2013;3:13 doi:10.1186/2191-1991-3-13

Homar F, Lozano V, Martínez-Gómez J, Oyagüez I, Pareja A, Payeras A, Serrano J, Carmen Carratalá, Casado MA

 

 

Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs
Health Econ Rev. 2012,2:16

García-Ruiz A, Perez-Costillas L, Montesinos AC, Alcalde J, Oyagüez I, Casado MA

 

 

Efficiency of antipsychotics in reducing schizophrenia relapses
Health Econ Rev. 2012;2:8

Martínez-Raga J, González-Saiz F, Oñate J, Oyagüez I, Sabater E, Casado MA

 

 

Budgetary impact analysis of Buprenorphine-Naloxone combination (Suboxone®) in Spain
Health Econ Rev. 2012;2:3 doi:10.1186/2191-1991-2-3